Treating critically ill patients with probiotics: Beneficial or dangerous?

Gut Pathogens

Volumn 3, Issue 1, 2011, Pages

  Jacobi, Christoph A ^a   Schulz, Christian ^a   Malfertheiner, Peter ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79960779117     PISSN: None     EISSN: 17574749     Source Type: Journal    
DOI: 10.1186/1757-4749-3-2     Document Type: Review

References (24)

1. Influence of the critically ill state on host-pathogen interactions within the intestine: gut-derived sepsis redefined. Alverdy JC, Laughlin RS, Wu L, Crit Care Med 2003 31 598 607 10.1097/01.CCM.0000045576.55937.67 12576972 (Pubitemid 36232961)
2. Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients. Bengmark S, Clin Nutr 2004 23 441 5 10.1016/j.clnu.2004.01.005 15297078 (Pubitemid 39107021)
3. Probiotics in critically ill patients. Madsen K, J Clin Gastroenterol 2008 42 116 8 10.1097/MCG.0b013e31817283cb
4. Ventilator-associated pneumonia. Chastre J, Fagon JY, Am J Respir Crit Care Med 2002 165 867 903 11934711 (Pubitemid 34774654)
5. Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial. Knight DJ, Gardiner D, Banks A, Snape SE, Weston VC, Bengmark S, Girling KJ, Intensive Care Med 2009 35 854 61 10.1007/s00134-008- 1368-1 19083199
6. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH, VAP Outcomes Scientific Advisory Group, Chest 2002 122 2115 21 10.1378/chest.122.6.2115 12475855 (Pubitemid 36051151)
7. Probiotics for the prevention of nosocomial pneumonia: current evidence and opinions. McNabb B, Isakow W, Curr Opin Pulm Med 2008 14 168 75 10.1097/MCP.0b013e3282f76443 18427239 (Pubitemid 351572317)
8. Probiotic use in the critically ill. Singhi SC, Baranwal A, Indian J Pediatr 2008 75 621 7 10.1007/s12098-008-0119-1 18759092
9. Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases. Penner R, Fedorak RN, Madsen KL, Curr Opin Pharmacol 2005 5 596 603 10.1016/j.coph.2005.06.009 16214413 (Pubitemid 41614458)
10. Modification of intestinal flora with multispecies probiotics reduces bacterial translocation and improves clinical course in a rat model of acute pancreatitis. van Minnen LP, Timmerman HM, Lutgendorff F, Verheem A, Harmsen W, Konstantinov SR, Smidt H, Visser MR, Rijkers GT, Gooszen HG, Akkermans LM, Surgery 2007 141 470 80 10.1016/j.surg.2006.10.007 17383524 (Pubitemid 46441310)
11. Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. Jain PK, McNaught CE, Anderson AD, MacFie J, Mitchell CJ, Clin Nutr 2004 23 467 75 10.1016/j.clnu.2003.12.002 15297081 (Pubitemid 39107024)
12. A prospective randomised trial of probiotics in critically ill patients. McNaught CE, Woodcock NP, Anderson AD, MacFie J, Clin Nutr 2005 24 211 9 10.1016/j.clnu.2004.08.008 15784480 (Pubitemid 40392804)
13. Synbiotic control of inflammation and infection in severe acute pancreatitis: a prospective, randomized, double blind study. Oláh A, Belágyi T, Pátá L, Romics L Jr, Bengmark S, Hepatogastroenterology 2007 54 590 4 17523328 (Pubitemid 46724735)
14. Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial. Barraud D, Blard C, Hein F, Marçon O, Cravoisy A, Nace L, Alla F, Bollaert PE, Gibot S, Intensive Care Med 2010 20502866
15. Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. Alberda C, Gramlich L, Meddings J, Field C, McCargar L, Kutsogiannis D, Fedorak R, Madsen K, Am J Clin Nutr 2007 85 816 23 17344505 (Pubitemid 46393515)
16. Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. Spindler-Vesel A, Bengmark S, Vovk I, Cerovic O, Kompan L, JPEN J Parenter Enteral Nutr 2007 31 119 26 10.1177/0148607107031002119 17308252
17. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Oláh A, Belágyi T, Issekutz A, Gamal ME, Bengmark S, Br J Surg 2002 89 1103 7 12190674 (Pubitemid 34989215)
18. Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients. Forestier C, Guelon D, Cluytens V, Gillart T, Sirot J, De Champs C, Crit Care 2008 12 69 10.1186/cc6907 18489775 (Pubitemid 351796668)
19. Benefits of a synbiotic formula (Synbiotic 2000Forte) in critically Ill trauma patients: early results of a randomized controlled trial. Kotzampassi K, Giamarellos-Bourboulis EJ, Voudouris A, Kazamias P, Eleftheriadis E, World J Surg 2006 30 1848 55 10.1007/s00268-005-0653-1 16983476 (Pubitemid 44454998)
20. Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics. Klarin B, Wullt M, Palmquist I, Molin G, Larsson A, Jeppsson B, Acta Anaesthesiol Scand 2008 52 1096 102 10.1111/j.1399-6576.2008.01748.x 18840110
21. Probiotic Prophylaxis of Ventilator-associated Pneumonia: A Blinded, Randomized, Controlled Trial. Morrow LE, Kollef MH, Casale TB, Am J Respir Crit Care Med 2010 20522788
22. Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. Frohmader TJ, Chaboyer WP, Robertson IK, Gowardman J, Am J Crit Care 2010 19 1 11 10.4037/ajcc2010976 20436058
23. Probiotic therapy-recruiting old friends to fight new foes. Sleator RD, Gut Pathog 2010 2 5 10.1186/1757-4749-2-5 20579345
24. Enhancing bile tolerance improves survival and persistence of Bifidobacterium and Lactococcus in the murine gastrointestinal tract. Watson D, Sleator RD, Hill C, Gahan CG, BMC Microbiol 2008 8 176 10.1186/1471-2180-8-176 18844989